These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 11673456
21. Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth. Cheng ZJ, Harikumar KG, Holicky EL, Miller LJ. J Biol Chem; 2003 Dec 26; 278(52):52972-9. PubMed ID: 14534299 [Abstract] [Full Text] [Related]
25. Applications of fluorescence in the characterization of the ligand-binding domain and activation of the cholecystokinin receptor. Harikumar KG, Miller LJ. Pharmacol Toxicol; 2002 Dec 17; 91(6):286-9. PubMed ID: 12688370 [Abstract] [Full Text] [Related]
28. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer. Blanquart C, Boute N, Lacasa D, Issad T. Mol Pharmacol; 2005 Sep 17; 68(3):885-94. PubMed ID: 15976035 [Abstract] [Full Text] [Related]
31. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179. Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D. Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190 [Abstract] [Full Text] [Related]
32. Direct Coupling of a Seven-Transmembrane-Span Receptor to a Gαi G-Protein Regulatory Motif Complex. Robichaux WG, Oner SS, Lanier SM, Blumer JB. Mol Pharmacol; 2015 Aug 01; 88(2):231-7. PubMed ID: 25972449 [Abstract] [Full Text] [Related]
36. Cholecystokinin-stimulated tyrosine phosphorylation of p125FAK and paxillin is mediated by phospholipase C-dependent and -independent mechanisms and requires the integrity of the actin cytoskeleton and participation of p21rho. García LJ, Rosado JA, González A, Jensen RT. Biochem J; 1997 Oct 15; 327 ( Pt 2)(Pt 2):461-72. PubMed ID: 9359417 [Abstract] [Full Text] [Related]
38. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Roettger BF, Ghanekar D, Rao R, Toledo C, Yingling J, Pinon D, Miller LJ. Mol Pharmacol; 1997 Mar 15; 51(3):357-62. PubMed ID: 9058588 [Abstract] [Full Text] [Related]
39. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist. Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ. Mol Pharmacol; 2004 Sep 15; 66(3):545-52. PubMed ID: 15322246 [Abstract] [Full Text] [Related]
40. Cholecystokinin activates PYK2/CAKbeta by a phospholipase C-dependent mechanism and its association with the mitogen-activated protein kinase signaling pathway in pancreatic acinar cells. Tapia JA, Ferris HA, Jensen RT, García LJ. J Biol Chem; 1999 Oct 29; 274(44):31261-71. PubMed ID: 10531323 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]